| RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES | |||||||||||||||
| Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Research and development expenses, as reported | $ | 240.7 | $ | 292.6 | $ | 482.4 | $ | 591.1 | |||||||
| Share-based compensation expense | (26.9 | ) | (23.7 | ) | (50.2 | ) | (46.6 | ) | |||||||
| Other adjustments | — | (0.2 | ) | — | (0.4 | ) | |||||||||
| Non-GAAP research and development expenses | $ | 213.8 | $ | 268.7 | $ | 432.2 | $ | 544.1 | |||||||
| GAAP research and development expenses as a percentage of net sales | 20.7 | % | 13.0 | % | 20.1 | % | 13.0 | % | |||||||
| Non-GAAP research and development expenses as a percentage of net sales | 18.4 | % | 11.9 | % | 18.0 | % | 12.0 | % | |||||||
Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2025
 |  | More IC News
|
|
RELATED NEWS
